Advances in the Study of Bioactive Nanoparticles for the Treatment of HCC and Its Postoperative Residual Cancer

Primary hepatocellular carcinoma (HCC, hepatocellular carcinoma) is the third leading cause of tumor death in the world and the second leading cause in China. The high recurrence rate at 5 years after surgery also seriously affects the long-term survival of HCC patients. For reasons such as poor liv...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yanxu, Zou, Hao, Zheng, Zekun, Liu, Zhuoheng, Hu, Huiyuan, Wu, Wei, Wang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216871/
https://www.ncbi.nlm.nih.gov/pubmed/37250475
http://dx.doi.org/10.2147/IJN.S399146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216871/
https://www.ncbi.nlm.nih.gov/pubmed/37250475
http://dx.doi.org/10.2147/IJN.S399146

Ejemplares similares